Our firm recently performed two valuations on a pharmaceutical company two years apart. The owners were surprised by the surprisingly large jump in value, far larger than performance improvement might have justified.

When investing in equities, investors have two main choices: common stocks or preferred shares.  Whereas the previous article in this series dealt with common shares, this article focuses on preferred shares.

When investing in equities, investors have two main choices: common stocks or preferred shares.  Whereas the previous article in this series dealt with common shares, this article focuses on preferred shares.